Most recent update: Sunday, April 29, 2018 - 14:56
You are here
News
Acquisition
Becton, Dickinson and Company (BD) has completed the acquisition of CR Bard, a transaction that was first announced in April 2017, for US$24 billion. The combined company, which will have...
Protease-modulating matrix
A Chochrane review examining evidence on the effects of treatments designed to lower the levels of protease in venous leg ulcers (VLUs) has found that the evidence from clinical trials is ‘unclear’...
VTE prophylaxis programme
The implementation of a Venous thromboembolism (VTE) prophylaxis programme that targeted adults admitted to a large hospital employing a multiple-strategy approach, achieved high rates of risk...
Statins and VTE
Statins could play an important role in reducing the risk of venous thromboembolism, according to research by Dr Setor Kunutsor and colleagues form the Musculoskeletal Research Unit in the School of...
Betrixaban approvals
Portola Pharmaceuticals has announced that the FDA has accepted Portola’s New Drug Application (NDA) granting priority review for betrixaban, an oral, once-daily Factor Xa inhibitor anticoagulant,...
- 1 of 2
- next ›
May-Thurner Syndrome
May-Thurner Syndrome (MTS) - sometimes inaccurately used in the literature to describe iliac vein compression - is more common in women with a ratio of at least 2:1 compared with men, according to a...
Venous leg ulcers
Early endovenous ablation of superficial venous reflux as an adjunct to compression therapy is associated with a shorter time to healing of venous leg ulcers than compression therapy alone, according...
SIR position statement on CDT
The Society of Interventional Radiology (SIR) has issued a position statement on catheter-directed therapy (CDT) for acute pulmonary embolism (PE), which stats that the society deems the use of CDT...
Leg ulcer guidance
The Royal Society of Medicine’s Venous Forum (UK) has issued a guidance document for the ‘Management of patients with Leg Ulcers, to ensure that all patients with leg ulceration are offered the most...
